期刊文献+

1998~2007年大连市水痘突破病例资料分析 被引量:12

Analysis of Varicella Break Cases in Dalian City from 1998 to 2007
原文传递
导出
摘要 [目的]了解大连市水痘疫苗接种后突破病例发病特点及规律。[方法]对1998~2007年水痘疫苗接种资料及突破病例资料进行分析。[结果]1998~2007年大连市共接种水痘疫苗85189人次,发生水痘突破病例64例,突破病例发生率为0.75%。;发病年龄1~9岁,呈单峰型,4岁为发病高峰;发病与接种疫苗时间间隔最短为24d.最长为4年9个月,平均2年;临床症状轻微。多数不发热,93.75%的病例皮疹少于50个,病程短,无并发症。[结论]接种水痘疫苗后极少数人可发生突破病例,提示在水痘疫苗预防接种过程中,应做好告知和解释工作,对发生的突破病例应进行妥善处理。 [Objective]To understand the character and regulation of varicella broken cases in Dalian city. [Methods] The data of varicella vaccination between 1998 and 2007 was accepted and the character of 64 broken cases was analyzed. [Results]85 189 children were immunized by varicella vaccine and 64 broken cases occurred after immunization,the occurrence rate was 0.75~/000, the age scope was from 1 years old to 9 years old, the age curve of occurrence was monomodal and 4 years old was the peak incidence,the shortest and longest duration was 24 days and 4 years plus 9 months respectively. The clinical symptom of all the cases was slight and the most did not have fever,93.75% of cases had less than 50s skin poxes, the illness course was short,all cases had no complications. [Conclusion]The broken cases can take place after immunization in pole children, hinting that during the immunization process, it should be worked well to tell and to reach agreement,also the appropriate processing should be carried out for broken cases.
出处 《预防医学论坛》 2009年第8期749-750,共2页 Preventive Medicine Tribune
关键词 预防接种 水痘疫苗 突破病例 Immunization Varicella vaccine Broken cases
  • 相关文献

参考文献3

二级参考文献27

  • 1庞成华,彭佩霞,刘小琳,王桂秋,陈秀珍,王用楫,白桂华.北京株水痘活疫苗的临床反应、血清学及流行病学效果[J].中国生物制品学杂志,1994,7(4):178-180. 被引量:7
  • 2Boot HJ, De Melker HE, Stolk EA, et al. Assessing the introduction of universal varicella vaccination in the Netherlands. Vaccine, 2006, 24( 37-39 ): 6288-6299.
  • 3I Cohen JI. Varicella-zoster vaccine virus: evolution in action. Proe Natl Acad Sci USA, 2007, 104(1 ): 7-8.
  • 4Tugwell BD, Lee LE, Gillette H, et al. Chickenpox outbreak in a highly vaccinated school population. Pediatrics, 2004, 113 (3 Pt 1 ): 455-459.
  • 5Lopez AS, Guris D, Zimmerman Let al. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose. Pediatrics, 2006, 117(6): e1070-1077.
  • 6Verstraeten T, Jumaan AO, Mullooly JP, et al. A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination. Pediatrics, 2003, 112(2): e98-103.
  • 7Levine MJ, Ellison MC, Zerbe GO, et al. Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella-specific immune response in seropositive people 55 years of age and older. Vaccine, 2000, 18(25): 2915-2920.
  • 8Galil K, Fair E, Mountcastle N, et al. Younger age at vaccination may increase risk of varicella vaccine failure. J Infect Dis, 2002, 186 ( 1 ): 102-105.
  • 9Holcomb K, Weinberg JM. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia. J Drugs Dermatol, 2006, 5 (9): 863-866.
  • 10Hata A, Asanuma H, Rinki M, et al. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med, 2002, 347( 1 ): 26-34.

共引文献53

同被引文献142

引证文献12

二级引证文献323

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部